Education
About Us
Working with TipRanks
Follow Us
Ceribell, Inc. (CBLL)
:CBLL
CBLL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$10.01 - $32.75
Previous CloseN/A
Volume46.56K
Average Volume (3M)322.29K
Market Cap
$545.04M
Enterprise Value$523.90M
Total Cash (Recent Filing)$177.43M
Total Debt (Recent Filing)$21.55M
Price to Earnings (P/E)―
Beta0.91
Next Earnings
Nov 18, 2025EPS Estimate
-0.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.38
Shares Outstanding36,143,020
10 Day Avg. Volume345,927
30 Day Avg. Volume322,291
Financial Highlights & Ratios
PEG Ratio-0.10
Price to Book (P/B)4.22
Price to Sales (P/S)12.34
P/FCF Ratio-22.20
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue6.77
Enterprise Value/Gross Profit7.71
Enterprise Value/Ebitda-10.85
Forecast
1Y Price Target
$29.00Price Target Upside90.41% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
EarningsQ2 revenue of $21.2M was up 38% and beat the Street's $20.5M forecast.
GuidanceFull-year revenue guidance was increased to $85M-$88M from $83M-87M.
Supply ChainCBLL has further de-risked its supply chain by establishing a production line in Vietnam, creating supply redundancy and allowing the company to potentially benefit from more favorable trade policies.
Bears Say
Geopolitical RisksCeribell is exposed to geopolitical risk due to its China-based manufacturing operations, which could impact gross margins with potential tariff changes.
Legal RisksCeribell announced a lawsuit against Natus Medical, alleging patent infringement on its BrainWatch EEG system.
Stock PerformanceThe stock has fallen 35% largely due to China manufacturing exposure and lock-up expiration.
Ceribell, Inc. News
CBLL FAQ
What was Ceribell, Inc.’s price range in the past 12 months?
Ceribell, Inc. lowest stock price was $10.01 and its highest was $32.75 in the past 12 months.
What is Ceribell, Inc.’s market cap?
Ceribell, Inc.’s market cap is $545.04M.
When is Ceribell, Inc.’s upcoming earnings report date?
Ceribell, Inc.’s upcoming earnings report date is Nov 18, 2025 which is in 102 days.
How were Ceribell, Inc.’s earnings last quarter?
Ceribell, Inc. released its earnings results on Aug 05, 2025. The company reported -$0.38 earnings per share for the quarter, beating the consensus estimate of -$0.397 by $0.017.
Is Ceribell, Inc. overvalued?
According to Wall Street analysts Ceribell, Inc.’s price is currently Undervalued.
Does Ceribell, Inc. pay dividends?
Ceribell, Inc. does not currently pay dividends.
What is Ceribell, Inc.’s EPS estimate?
Ceribell, Inc.’s EPS estimate is -0.42.
How many shares outstanding does Ceribell, Inc. have?
Ceribell, Inc. has 36,143,020 shares outstanding.
What happened to Ceribell, Inc.’s price movement after its last earnings report?
Ceribell, Inc. reported an EPS of -$0.38 in its last earnings report, beating expectations of -$0.397. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Ceribell, Inc.?
Currently, no hedge funds are holding shares in CBLL
Ceribell, Inc. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$29.00 (90.41% Upside)
$29.00 (90.41% Upside)
Blogger Sentiment
Bullish
CBLL Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 281.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 2.9%
Last 30 Days ▼ 2.9%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Company Description
Ceribell, Inc.
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.
CBLL Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth, high gross margins, expansion of active accounts, and important regulatory achievements, such as FDA clearance and FedRAMP authorization. However, the increase in operating expenses and net loss, along with potential impacts from increased tariffs, present challenges. Despite these lowlights, the positive aspects, including strategic achievements and financial growth, suggest a confident outlook.View all CBLL earnings summariesCBLL Stock 12 Month Forecast
Average Price Target
$29.00
▲(90.41% Upside)
Technical Analysis
Ownership Overview
27.99% Insiders
21.02% Mutual Funds
<0.01% Other Institutional Investors
44.33% Public Companies and
Individual Investors